Skip to content
Thursday, November 12, 2026
  • Home
  • Business
  • Domestic
  • Economy
  • Top News
  • Newsletters
Financial Wealth Daily

Financial Wealth Daily

  • Home
  • Business
  • Domestic
  • Economy
  • Top News
  • Newsletters
Financial Wealth Daily

Financial Wealth Daily

  • Home
  • Business
  • Domestic
  • Economy
  • Top News
  • Newsletters
  • Newsletters

Nvidia Lost $600 Billion This Week. The Real Problem Isn’t the Scandal.

Financial Wealth DailyNovember 12, 20260

Nvidia lost more than $600 billion in market value this week after reports surfaced that Jensen Huang had extramarital affairs…

  • Top News

Siemens Has a €143 Billion Backlog. The Market Still Prices It Like a European Also-Ran.

Financial Wealth DailyNovember 12, 20260

Record orders, record free cash flow, and a raised growth outlook put Europe’s largest industrial in a category the market has yet to price correctly.

  • Politics

Lyft’s Hidden Asset Is Worth More Than Its Stock Price

Financial Wealth DailyNovember 11, 20260

A regulatory charge knocked LYFT down after Q3. What it obscured is Flexdrive, the fleet operation that makes Lyft a serious acquisition candidate.

  • Newsletters

Altria Raises Its Dividend Again. The Engine Doing It May Surprise You.

Financial Wealth DailyNovember 11, 20260

Most income investors know Altria (NYSE: MO) for its yield. Fewer understand exactly how the company keeps funding it while…

  • Business

Nvidia Is Flat for 2026. The Scandal Is Only Part of the Story.

Financial Wealth DailyNovember 11, 20260

Congress set Nov. 11 as Jensen Huang’s answer-or-subpoena deadline. The valuation question matters too.

  • Economy

Ozempic and Zepbound Now Carry a Vision-Loss Warning. What It Means for NVO and LLY.

Financial Wealth DailyNovember 10, 20260

The FDA’s class-wide label update lands as a federal MDL with more than 2,000 cases heads toward discovery deadlines.

  • Newsletters

Arrowhead’s Heart Drug Cut Pancreatitis Risk by 78%

Financial Wealth DailyNovember 10, 20260

Two days before Arrowhead Pharmaceuticals reports fiscal Q4 2026 results, the company walked into the American Heart Association’s Scientific Sessions…

  • Economy

KKR Expects to Return $40+ Billion to Clients in 2026

Financial Wealth DailyNovember 10, 20260

A record 3Q fee base and $75 billion not yet paying fees show why the manager matters.

  • Politics

Rocket Lab Reports Tonight. The Iridium Deal Is the Test.

Financial Wealth DailyNovember 9, 20260

Revenue expected near $257M and an $8B deal closing in 2027. Tonight’s call sets the tone.

  • Newsletters

CoreWeave Is Growing at 160%. Its Bonds Are Yielding 15%.

Financial Wealth DailyNovember 9, 20260

CoreWeave reports third-quarter results Tuesday evening, and no earnings release this week carries a wider range of outcomes. CRWV stock…

  • 1
  • 2
  • 3
  • …
  • 42

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Sign up for our free Financial Wealth Daily Newsletter!

Discover new market trends and ideas directly to your inbox.

By providing your email, you agreed to receive informational and promotional messages from us. You may opt out at any time by clicking the unsubscribe at the bottom of each email. See our Privacy Policy for more information.

Recent Posts

  • Nvidia Lost $600 Billion This Week. The Real Problem Isn’t the Scandal.
  • Siemens Has a €143 Billion Backlog. The Market Still Prices It Like a European Also-Ran.
  • Lyft’s Hidden Asset Is Worth More Than Its Stock Price
  • Altria Raises Its Dividend Again. The Engine Doing It May Surprise You.
  • Nvidia Is Flat for 2026. The Scandal Is Only Part of the Story.
  • Ozempic and Zepbound Now Carry a Vision-Loss Warning. What It Means for NVO and LLY.
  • Arrowhead’s Heart Drug Cut Pancreatitis Risk by 78%

Categories

  • Business
  • Economy
  • Newsletters
  • Politics
  • Top News
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms of Service/Use Agreement
  • Contact Us
Copyright 2026 © All rights reserved | Financial Wealth Daily | financialwealthdaily.com
SITE_OK
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}